Preveceutical Medical Inc C.PREV

Alternate Symbol(s): PRVCF

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its BSV peptide program targets cancer progression. Its Non-Addictive Analgesic is an engineering non-addictive analgesic peptide for pain management. Its Dual Gene Therapy targets type 2 diabetes and obesity. The Company’s subsidiary, PreveCeutical (Australia) Pty Ltd., manages its research programs.

CSE:PREV - Post by User

Preveceutical Medical Inc > Prev webinar tomorrow

<< Previous

Bullboard Posts

Next >>

Comment by MrQuarterson Aug 18, 2020 9:33pm

159 Views

Post# 31426134

RE:RE:Prev webinar tomorrow

I did, I even had my question answered. Basically asked what timeline we are looking at for sol gel solution to be finalized, human trials finalized product to market. In short, expect 6 months for product to market and revenue being generated.

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles